- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x GT5: ~{N}-[(2~{S})-1-[[(2~{S})-1-[[(2~{S})-1-[4-(aminomethyl)phenyl]-4-methylsulfonyl-butan-2-yl]amino]-3-methoxy-1-oxidanylidene-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xin, B.T. et al., Structure-Based Design of Inhibitors Selective for Human Proteasome beta 2c or beta 2i Subunits. J.Med.Chem. (2019)
- Release Date
- 2019-01-30
- Peptides
- Proteasome subunit alpha type-2: AO
Proteasome subunit alpha type-3: BP
Proteasome subunit alpha type-4: CQ
Proteasome subunit alpha type-5: DR
Proteasome subunit alpha type-6: ES
Probable proteasome subunit alpha type-7: FT
Proteasome subunit alpha type-1: GU
Proteasome subunit beta type-10,Proteasome subunit beta type-2: HV
Proteasome subunit beta type-3: IW
Proteasome subunit beta type-4: JX
Proteasome subunit beta type-5: KY
Proteasome subunit beta type-6: LZ
Proteasome subunit beta type-7: M0
Proteasome subunit beta type-1: N1 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AO
OB
BP
PC
CQ
QD
DR
RE
ES
SF
FT
TG
GU
UH
HV
VI
IW
WJ
JX
XK
KY
YL
LZ
ZM
M0
aN
N1
b